Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money.
Spurred by AI’s possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund
This was originally published on post